Business · 27/07/2016Updated: 10/17/2026 · 1 min read
FDA Announces Generic Drug User Fee Rates for FY 2017
Summary
The Food and Drug Administration (FDA) has set the fees for abbreviated new drug applications, prior approval supplements, and other related applications for fiscal year 2017, as mandated by the Generic Drug User Fee Program.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →